Clinical trials
Observational Sjogren's Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 6 |
| Terminated | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Dental and Craniofacial Research (NIDCR) | 10 |
| Children's Hospital of Philadelphia | 2 |
| Duke University | 2 |
| Johns Hopkins University | 2 |
| University of Pennsylvania | 2 |
| Alcon Research | 1 |
| Biogen | 1 |
| Dompé Farmaceutici S.p.A | 1 |
| Emory University | 1 |
| HOB Biotech Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sjogren's Syndrome | 35 |
| Lupus Erythematosus, Systemic | 9 |
| Arthritis, Rheumatoid | 8 |
| Autoimmune Diseases | 7 |
| Dry Eye Syndromes | 7 |
| Scleroderma, Diffuse | 7 |
| Xerostomia | 6 |
| Spondylitis, Ankylosing | 5 |
| Arthritis, Psoriatic | 3 |
| Dermatomyositis | 3 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.